Form 4: Intuitive Surgical Executive Robert DeSantis Executes Stock Options and Sells Shares Under 10b5-1 Trading Plan

Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Robert DeSantis, an executive at Intuitive Surgical, executed non-qualified stock options and sold shares of Intuitive Surgical common stock on August 28 and 29, 2024.
• The transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• On both days, 188 shares were acquired through option exercise and 188 shares were sold on the open market.
• The exercise prices for the options were $208.9 and $290.33, while the sale prices were $482.93 and $482.21.
• Following these transactions, DeSantis directly owns 5,506 shares of Intuitive Surgical common stock and holds options to purchase 3,384 shares at exercise prices of $208.9 and $290.33.
• The trading plan expires on December 9, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects routine executive stock transactions under a pre-arranged plan. There is no indication of positive or negative sentiment towards the company's prospects.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Future Outlook

The executive's trading activity will continue under the 10b5-1 plan until its expiration on December 9, 2024.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include stock options as a significant component.
• The vesting schedules and exercise prices of these options are typically structured to align executive incentives with long-term shareholder value creation.
• Companies like Stryker, Medtronic, and Johnson & Johnson also utilize stock options as part of their executive compensation plans.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the relatively small volume of shares involved.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates